Explore All Access
Check if your research matches the topics covered in Annals of the Rheumatic Diseases?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Annals of the Rheumatic Diseases : Impact Factor & More
eISSN: 1468-2060pISSN: 0003-4967
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Annals of the Rheumatic Diseases Key Metrics
CiteScore 
28.5
H-Index
272
SJR
Q1Immunology
SNIP
5.22
Time to Accept
3
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months36%
4 to 6 months50%
7 to 9 months13%
Above 9 months2%
Did you find this useful?
Topics Covered on Annals of the Rheumatic Diseases
Rheumatoid arthritis
Connective tissue
Disease activity
Gout
Glucocorticoid
Ankylosing spondylitis
Rheumatology
Lupus erythematosus
Questionnaire
Arthritis
Osteoarthritis
Allele
Nuclear magnetic resonance
Fibromyalgia
Psoriasis
Quality of life
Antigen
Psoriatic arthritis
Saliva
Osteoporosis
Annals of the Rheumatic Diseases Journal Specifications
| Overview | |
| Publisher | BMJ PUBLISHING GROUP |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1935 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Annals of the Rheumatic Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Annals of the Rheumatic Diseases
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
- 28 Nov 2024
- Annals of the Rheumatic Diseases
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
- 27 Nov 2024
- Annals of the Rheumatic Diseases
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
- 27 Nov 2024
- Annals of the Rheumatic Diseases
Correction: Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
- 27 Nov 2024
- Annals of the Rheumatic Diseases
Pharmacodynamics of the S1P1 receptor modulator cenerimod in a phase 2b randomised clinical trial in patients with moderate to severe SLE
- 22 Nov 2024
- Annals of the Rheumatic Diseases
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis
- 20 Nov 2024
- Annals of the Rheumatic Diseases
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
- 28 Nov 2024
- Annals of the Rheumatic Diseases
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
- 27 Nov 2024
- Annals of the Rheumatic Diseases
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
- 27 Nov 2024
- Annals of the Rheumatic Diseases
Correction: Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
- 27 Nov 2024
- Annals of the Rheumatic Diseases
Pharmacodynamics of the S1P1 receptor modulator cenerimod in a phase 2b randomised clinical trial in patients with moderate to severe SLE
- 22 Nov 2024
- Annals of the Rheumatic Diseases
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis
- 20 Nov 2024
- Annals of the Rheumatic Diseases
Compare Similar Journals with Annals of the Rheumatic Diseases
Select Journals to Compare with Annals of the Rheumatic Diseases
Total journals - 8
You can select up to 3 Journals at a time
Rheumatology
Publisher: OXFORD UNIV PRESS
Clinical Rheumatology
Publisher: SPRINGER LONDON LTD
Arthritis Research and Therapy
Publisher: BMC
Journal of Rheumatology
Publisher: J RHEUMATOL PUBL CO
Rheumatology International
Publisher: SPRINGER HEIDELBERG
International Journal of Rheumatic Diseases
Publisher: WILEY
Seminars in Arthritis and Rheumatism
Publisher: W B SAUNDERS CO-ELSEVIER INC
RMD Open
Publisher: BMJ PUBLISHING GROUP
0 Journals Selected to compare with
Annals of the Rheumatic Diseases
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Annals of the Rheumatic Diseases
How long has Annals of the Rheumatic Diseases been actively publishing? 
Annals of the Rheumatic Diseases has been in operation since 1935 till date.
What is the publishing frequency of Annals of the Rheumatic Diseases?
Annals of the Rheumatic Diseases published with a Monthly frequency.
How many articles did Annals of the Rheumatic Diseases publish last year?
In 2023, Annals of the Rheumatic Diseases publsihed 3931 articles.
What is the eISSN & pISSN for Annals of the Rheumatic Diseases?
For Annals of the Rheumatic Diseases, eISSN is 1468-2060 and pISSN is 0003-4967.
What is Citescore for Annals of the Rheumatic Diseases?
Citescore for Annals of the Rheumatic Diseases is 28.5.
What is the H Index for Annals of the Rheumatic Diseases ?
H Index for Annals of the Rheumatic Diseases is 272.
What is SNIP score for Annals of the Rheumatic Diseases?
SNIP score for Annals of the Rheumatic Diseases is 5.22.
What is the SJR for Annals of the Rheumatic Diseases?
SJR for Annals of the Rheumatic Diseases is Q1.
Who is the publisher of Annals of the Rheumatic Diseases?
BMJ PUBLISHING GROUP is the publisher of Annals of the Rheumatic Diseases.
